Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens U Rüggeberg

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Paediatric Drugs|September 2, 2004
Meningococcal vaccinesJens U Rüggeberg, Andrew J Pollard
Vaccine|April 5, 2014
Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trialRoman Prymula, Petr Pazdiora, Magali Traskine, et al.
Vaccine|March 11, 2014
Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical studyGeert Leroux-Roels, Cathy Maes, Fien De Boever, et al.
Human Vaccines & Immunotherapeutics|December 21, 2013
Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of lifeOlumuyiwa O Odusanya, Yetunde A Kuyinu, Omolara A Kehinde, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Paediatric Drugs|September 2, 2004
Meningococcal vaccinesJens U Rüggeberg, Andrew J Pollard
Vaccine|April 5, 2014
Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trialRoman Prymula, Petr Pazdiora, Magali Traskine, et al.
Vaccine|March 11, 2014
Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical studyGeert Leroux-Roels, Cathy Maes, Fien De Boever, et al.
Human Vaccines & Immunotherapeutics|December 21, 2013
Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of lifeOlumuyiwa O Odusanya, Yetunde A Kuyinu, Omolara A Kehinde, et al.
Pageof 1